Efficacy of rituximab in Felty's syndrome.
Shipley
Emilie
E
Héraud
Alain
A
Hennette
Amélie
A
Vernhes
Jean-Philippe
JP
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005258:Felty Syndrome / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D009503:Neutropenia / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D000069283:Rituximab; D011241:Prednisone